SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Pluristem Therapeutics
PSTI 8.720+0.2%Aug 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: xcentral19/6/2011 9:34:44 AM
   of 295
 
Pluristem Therapeutics to Present at Leading U.S. Industry Conferences

HAIFA, Israel, Sep 6, 2011 (GlobeNewswire via COMTEX) -- Pluristem Therapeutics, Inc. (Nasdaq:PSTI) (TASE:PLTR) announced today that Company executives will be presenting at five leading scientific and financial events in the U.S. during the month of September. The presentations will focus on Pluristem's work towards the potential development of placenta-derived stem cell treatments for a variety of illnesses as well as on the company's strategy.
During the month of September, Pluristem will be presenting at the following conferences:

-- 35th Annual Meeting of the AATB - September 8-12, Scottsdale, Arizona.

Dr. William R. Prather, Sr. VP Corporate Development, will
present: "The use of Placenta-derived MSCs in the treatment of radiation
exposure" on Sunday, September 11, 2011 from 3:15 to 4:15 PM

-- Rodman & Renshaw Conference - September 11-13, New York, New York.
Yaky Yanay, VP Finance and CFO, will present: "Cell Therapy and Its
Future Role in Reducing Healthcare Spending" on Tuesday, September 13,
2:00-2:25 PM, Sutton Suite

-- UBS Global Life Sciences Conference - September 19-21, New York, New
York.
Zami Aberman, Chairman and CEO, will present the Company on
Tuesday, September 20, 2011 at 4:00 PM

-- The Cell Therapy Commercialization Summit - September 19-21, 2011,
Boston, Massachusetts.
Dr. William R. Prather, Sr. VP of
Corporate Development, will present the Company on Monday, September 19,
2011, 9:00-9:30 AM

-- 8th Annual Israel Strategic Partner and Venture Conference-Life Sciences
and Medical Devices - September 22, 2011, Princeton, New Jersey.
Dr. William R. Prather, Sr. VP of Corporate Development, will present
the Company

-- European Society of Cardiology: International Conference on Heart
Failure with Preserved Ejection Fraction: Basic mechanisms - September
23-25, Budapest, Hungary.
Frida Grynspan, PhD, VP of Research and
Development, will present: "HFPEF and stem cells" Session VII --
Therapy, on Sunday, September 25, 2011 10:20-10:40 AM.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext